MedPath

A Clinical Trial of Tulsi Original Green Tea in reducing daily stress

Phase 4
Not yet recruiting
Conditions
Daily Stress
Registration Number
CTRI/2020/07/026935
Lead Sponsor
Gujarat Tea Processors and Packers Ltd
Brief Summary

Tulsi(Ossimum Sanctum) is known as Basil leaves are regarded as an ’adaptogen’ oranti-stress agent.  Recent studies have shown that the leaves affordsignificant protection against stress. It has several known health benefits inrespiratory disorders, diabetes mellitus, skin disorders, pain management andacts also as immune modulators.

This clinical study has been planned to assess theability of mixture of Ram tulsi, Shyam tulsi and Vanatulsi Green Tea (TulsiOriginal Green Tea) in reducing Day to day stress in normal individual.  The study also intends tocheck the immunological response of Tulsi Original Green Tea in normalindividual.  Almost 82 per cent of India’spopulation are suffering from stress and those in the sandwich generation (aged35-49) are most affected with around 89 per cent reporting some level ofstress, reveals the Cigna’s 360 well-being survey 2019.

Department of Roganidan and PSAM Hospital will beinvolved for 3 months period and the sample single group size will be 30.

The Material and Methodsshall be Tulsi Original Green Tea will be distributedto people in the vicinity of Kalol who are voluntarily agreeing to participatein the trial and sign consent letter. Individuals participating in the trialwill be assessed with subjective parameters like Pittsburg Sleep Quality Index (PSQI)questionnaire and  Hamilton Depression Rating Scale (HDRS) to assess dayto day stress level on 1st  day, on 15th  dayand on 30th  day. Objective parameters like Routine BPmeasuring on every visit, CBC,ESR, LFT, RFT, IgG, IgE, Anti oxidants will alsobe carried out before and after the study to ascertain the immune responsedeveloped by the Individual.

The proposed outcome isthat Tulsi Original Green Tea is expected to be haveeffective result on reliving day to day stress in normal individuals; it alsoshould bring about immune-modulatory effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Healthy Volunteer willing to participate in the study and signed informed consent.

Exclusion Criteria

Patients with any systemic disorders Patients having depression and on medication for any psychiatric disorder Pregnant Women Patients who are under other investigational drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Users may cope better with day to day stress level30 days
May have improved sleep30 days
quality30 days
Improved anti oxidant serum level30 days
Secondary Outcome Measures
NameTimeMethod
Immuno modulatory effectImproved metabolism

Trial Locations

Locations (1)

Shree Swaminarayan Ayurvedic College Hospital

🇮🇳

Gandhinagar, GUJARAT, India

Shree Swaminarayan Ayurvedic College Hospital
🇮🇳Gandhinagar, GUJARAT, India
Dr M Sreedhar Rao
Principal investigator
6351047973
sreeayush@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.